8-K
DYNATRONICS CORP (DYNTQ)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_____________________________________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 29, 2021
__________________________________________
Dynatronics Corporation
(Exact name of registrant as specified in its charter)
__________________________________________
| Utah | 0-12697 | 87-0398434 |
|---|---|---|
| (State<br>or other jurisdiction of incorporation) | Commission<br>File Number | (IRS<br>Employer Identification Number) |
| 1200 Trapp Rd, Eagan, Minnesota | 55121 | |
| --- | --- | |
| (Address<br>of principal executive offices) | (Zip<br>Code) | |
| (801) 568-7000 | ||
| (Registrant's telephone number,<br>including area code) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14(d)-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
|---|---|---|
| Common<br>stock, no par value | DYNT | The<br>Nasdaq Capital Market |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 7.01 Regulation FD Disclosure.
On January 29, 2021, Dynatronics Corporation issued a press release to announce that it would release its earnings and results of operations on February 11, 2021 and hold a conference call with management to discuss the results. A copy of the release is attached to this Current Report on Form 8-K. The information set forth under this Item 7.01 and in the attached Exhibit 99.1 is deemed to be “furnished” and shall not be deemed to be “filed” for purposes of Section 18 of the Exchange Act, and is not incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.
Item 9.01
Financial Statements and Exhibits
| Exhibit Number | Description |
|---|---|
| 99.1 | Press<br>Release dated January 29, 2021 |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Date:<br>January 29, 2021 | DYNATRONICS CORPORATION | |
|---|---|---|
| By: | /s/John<br>Krier | |
| Name: John<br>Krier | ||
| Title: | Chief<br>Executive Officer |
dynt_ex991
Exhibit 99.1
Dynatronics Corporation Schedules Conference Call to Report
Results for Second Quarter of Fiscal Year 2021
Eagan, MN (January 29, 2021) – Dynatronics Corporation (NASDAQ:DYNT), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, today announced that the Company will release financial results for its fiscal second quarter, period ended December 31, 2020 on Thursday, February 11, 2021. The Company will subsequently hold a conference call, consisting of prepared remarks, a question and answer session and accompanied slide presentation, beginning at 8:30 AM ET on Thursday, February 11, 2021 to review its fiscal year 2021 second quarter results.
Interested persons may access the live call by dialing 888-506-0062 (U.S./Canada callers) or 973-528-0011 (international callers). It is recommended that participants call or log on 10 minutes ahead of the scheduled start time to ensure proper connection. A replay will be available one hour after the live call until Midnight on February 18, 2021, by dialing 877-481-4010, using passcode 39738. The slide presentation will be available by registering at https://www.webcaster4.com/Webcast/Page/2226/39738.
About Dynatronics Corporation
Dynatronics Corporation is a leading medical device company committed to providing high-quality restorative products designed to accelerate achieving optimal health. The Company designs, manufactures, and sells a broad range of products for clinical use in physical therapy, rehabilitation, pain management, and athletic training. Through its distribution channels, Dynatronics markets and sells to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, hospitals, and consumers. The Company’s products are marketed under a portfolio of high-quality, well-known industry brands including Bird & Cronin®, Solaris™, Hausmann™, Physician’s Choice®, and PROTEAM™, among others. More information is available at www.dynatronics.com.
Investor Contacts:
Dynatronics Corporation
Investor Relations
Skyler Black
(801) 676-7201
skyler.black@dynatronics.com
Darrow Associates
Peter Seltzberg, Managing Director
(516) 419-9915
pseltzberg@darrowir.com
For additional information, please visit: www.dynatronics.com
Connect with Dynatronics on LinkedIn